Form Type: 4/A

SEC EDGAR Link
Accession Number:0001104659-20-023928
Date:2020-02-14
Issuer: SCPHARMACEUTICALS INC. (SCPH)
Original Submission Date:2020-02-19

Reporting Person:

RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116

Reporting Person:

RA CAPITAL HEALTHCARE FUND LP
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR BOSTON, MA 02116

Reporting Person:

KOLCHINSKY PETER
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR BOSTON, MA 02116

Reporting Person:

SHAH RAJEEV M.
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR BOSTON, MA 02116

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-14 P 271,993 a $8.20 3,518,998 indirect f2,f3,f4
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 following the reported transactions, ra capital healthcare fund, l.p. (the "fund") held 2,877,503 shares and a separately managed account (the "account") held 641,495 shares.
f2 ra capital management, l.p. (the "adviser") is the investment manager for the fund and the account. the general partner of the adviser is ra capital management gp, llc (the "adviser gp"), of which dr. peter kolchinsky and mr. rajeev shah are the managing members.
f3 the adviser, the adviser gp, dr. kolchinsky, and mr. shah may be deemed indirect beneficial owners of the reported securities for purposes of section 13(d) of the securities exchange act of 1934 (the "act"). they disclaim beneficial ownership of any of the reported securities for the purpose of determining whether they are subject to section 16 of the act, however, in reliance on rule 16a-1(a)(1)(v) and (vii). to the extent that they might be deemed subject to section 16, they disclaim beneficial ownership of securities held by the fund for purposes of rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, and disclaim any pecuniary interest in securities held in the account for purposes of rule 16a-1(a)(2).
f4 the filing of this form 4 shall not be construed as an admission that either the adviser, the adviser gp, dr. kolchinsky, or mr. shah is or was for the purposes of section 16(a), or otherwise, the beneficial owner of any of the securities held in the account.
f5 due to a clerical error, the form 4 filed on february 19, 2020 inadvertently reflected an inaccurate amount of securities beneficially owned following reported transaction(s) in table i box 5. this amendment is being filed to correct and restate table i box 5. all other information set forth in the february 19, 2020 form 4 remains correct.
WhaleWisdom Logo

Elevate your investments